NMT Medical was founded in July 1986. In August 2002, the company sold its neurosciences business to Integra LifeSciences Holdings. NMT Medical has focused their business growth strategy to concentrate on the manufacturing, marketing and selling of the CardioSEAL(R) cardiac septal repair devices. Future sales growth and financial results are highly dependent upon the growth of sales of this product line. Future success will depend on the company's ability to manage and implement a focused business strategy effectively, including by: improving sales and marketing capabilities; continuing to train, motivate and manage employees; and developing and improving operational, financial and other internal systems. NMT Neurosciences is a subsidiary of NMT Medical. NMT Neurosciences specializes in providing neurosurgeons and their patients with high quality implantables and disposables for CSF Management and aneurysms.